Running Alpha sees Big Turnaround is very near for Biotech IBB
Running Alpha Capital Markets Macro-Strategist notes that 
IBB is thrusting into local lows on lighter volume, and given the strong relative strength of this sector, and given the extent of the recent pullback, we are virtually at or very near levels in both time and price to consider allocating into into this sector. Any time near or after August 13th opens up a new cycle, where any bullish action off these lows; and especially on a breakout above $378, would ignite new life in the NASDAQ Biotech ETF ( IBB ).
IBB is thrusting into local lows on lighter volume, and given the strong relative strength of this sector, and given the extent of the recent pullback, we are virtually at or very near levels in both time and price to consider allocating into into this sector. Any time near or after August 13th opens up a new cycle, where any bullish action off these lows; and especially on a breakout above $378, would ignite new life in the NASDAQ Biotech ETF ( IBB ).
Related publications
Disclaimer
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.